The veterinary vaccines market size has grown strongly in recent years. It will grow from $12.54 billion in 2025 to $13.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of animal diseases, rising livestock population, growth in companion animals, government regulations supporting vaccination, advancements in vaccine research and production.
The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $16.79 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to emerging biopharmaceutical vaccine technologies, rising demand for preventive veterinary care, adoption of dna and recombinant vaccines, expansion of vaccination programs in emerging markets, increasing awareness of zoonotic disease prevention. Major trends in the forecast period include development of novel livestock vaccines, growth in companion animal vaccination programs, expansion of recombinant and toxoid vaccines, adoption of multi-disease combination vaccines, focus on preventing zoonotic disease transmission.
The rising number of animals affected by various diseases is expected to drive the growth of the veterinary vaccine market in the coming years. Animals suffering from multiple diseases refers to non-human animals experiencing concurrent or sequential pathological conditions, resulting in compounded physical, psychological, and functional harm that severely affects their welfare. This increase is largely due to poor sanitation and hygiene in animal habitats. Veterinary vaccines support these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and improve overall health and welfare. For example, in July 2025, according to the UK Health Security Agency, a UK-based government organization, 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) were reported in 2024, marking an 11.6% increase from 138 cases in 2023. Therefore, the growing number of animals affected by multiple diseases is propelling the veterinary vaccine market.
Key players in the veterinary vaccine market are developing new products to maintain a competitive edge. These new products include advanced, disease-specific vaccines with improved formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched Circumvent CML, a three-in-one swine vaccine. This vaccine protects against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2D (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. By combining multiple antigens and adjuvant systems in a single bottle, it reduces the required dosage and is administered as a single intramuscular injection to pigs aged three weeks or older, simplifying vaccination and reducing stress for both animals and caretakers.
In April 2024, Virbac SA, a France-based provider of animal health products and services, including pharmaceuticals, vaccines, and preventive care solutions for companion and farm animals, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. Through this acquisition, Virbac aimed to strengthen its presence in the Asia Pacific animal health market and enhance its vaccine and pharmaceutical portfolio, particularly in farm animal segments, by integrating Sasaeah’s established manufacturing, R&D capabilities, and strong regional distribution network. Sasaeah Pharmaceutical Co. Ltd., based in Japan, develops, manufactures, and markets a broad range of veterinary pharmaceutical products and vaccines for major species, including cattle and other farm animals, supported by facilities in Japan and Vietnam.
Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.
North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary vaccines market by increasing costs for imported vaccines, biological raw materials, and cold-chain equipment, particularly affecting asia-pacific and european regions with high reliance on imports. This has influenced procurement and pricing for livestock and companion animal vaccines. On the positive side, tariffs have encouraged local vaccine production and innovation, leading to development of cost-effective alternatives and strengthening regional supply chains for long-term market resilience.
The veterinary vaccines market research report is one of a series of new reports that provides veterinary vaccines market statistics, including veterinary vaccines industry global market size, regional shares, competitors with a veterinary vaccines market share, detailed veterinary vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. This veterinary vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A veterinary vaccine is a biological preparation designed to stimulate the immune response of an animal, aiming to reduce animal suffering, prevent the transmission of microorganisms within the animal population, and enhance the immune strength of animals for improved health. Additionally, veterinary vaccines play a crucial role in preventing the transmission of diseases from animals to humans.
Various types of veterinary vaccines include live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine variants. Inactivated vaccines, distinct from live attenuated vaccines, consist of dead or inactivated viruses and bacteria. The diseases targeted by these vaccines encompass anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome. The application areas for veterinary vaccines extend to both livestock vaccines and companion animal vaccines.
The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $16.79 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to emerging biopharmaceutical vaccine technologies, rising demand for preventive veterinary care, adoption of dna and recombinant vaccines, expansion of vaccination programs in emerging markets, increasing awareness of zoonotic disease prevention. Major trends in the forecast period include development of novel livestock vaccines, growth in companion animal vaccination programs, expansion of recombinant and toxoid vaccines, adoption of multi-disease combination vaccines, focus on preventing zoonotic disease transmission.
The rising number of animals affected by various diseases is expected to drive the growth of the veterinary vaccine market in the coming years. Animals suffering from multiple diseases refers to non-human animals experiencing concurrent or sequential pathological conditions, resulting in compounded physical, psychological, and functional harm that severely affects their welfare. This increase is largely due to poor sanitation and hygiene in animal habitats. Veterinary vaccines support these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and improve overall health and welfare. For example, in July 2025, according to the UK Health Security Agency, a UK-based government organization, 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) were reported in 2024, marking an 11.6% increase from 138 cases in 2023. Therefore, the growing number of animals affected by multiple diseases is propelling the veterinary vaccine market.
Key players in the veterinary vaccine market are developing new products to maintain a competitive edge. These new products include advanced, disease-specific vaccines with improved formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched Circumvent CML, a three-in-one swine vaccine. This vaccine protects against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2D (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. By combining multiple antigens and adjuvant systems in a single bottle, it reduces the required dosage and is administered as a single intramuscular injection to pigs aged three weeks or older, simplifying vaccination and reducing stress for both animals and caretakers.
In April 2024, Virbac SA, a France-based provider of animal health products and services, including pharmaceuticals, vaccines, and preventive care solutions for companion and farm animals, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. Through this acquisition, Virbac aimed to strengthen its presence in the Asia Pacific animal health market and enhance its vaccine and pharmaceutical portfolio, particularly in farm animal segments, by integrating Sasaeah’s established manufacturing, R&D capabilities, and strong regional distribution network. Sasaeah Pharmaceutical Co. Ltd., based in Japan, develops, manufactures, and markets a broad range of veterinary pharmaceutical products and vaccines for major species, including cattle and other farm animals, supported by facilities in Japan and Vietnam.
Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.
North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary vaccines market by increasing costs for imported vaccines, biological raw materials, and cold-chain equipment, particularly affecting asia-pacific and european regions with high reliance on imports. This has influenced procurement and pricing for livestock and companion animal vaccines. On the positive side, tariffs have encouraged local vaccine production and innovation, leading to development of cost-effective alternatives and strengthening regional supply chains for long-term market resilience.
The veterinary vaccines market research report is one of a series of new reports that provides veterinary vaccines market statistics, including veterinary vaccines industry global market size, regional shares, competitors with a veterinary vaccines market share, detailed veterinary vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. This veterinary vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A veterinary vaccine is a biological preparation designed to stimulate the immune response of an animal, aiming to reduce animal suffering, prevent the transmission of microorganisms within the animal population, and enhance the immune strength of animals for improved health. Additionally, veterinary vaccines play a crucial role in preventing the transmission of diseases from animals to humans.
Various types of veterinary vaccines include live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine variants. Inactivated vaccines, distinct from live attenuated vaccines, consist of dead or inactivated viruses and bacteria. The diseases targeted by these vaccines encompass anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome. The application areas for veterinary vaccines extend to both livestock vaccines and companion animal vaccines.
The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Veterinary Vaccines Market Characteristics
3. Veterinary Vaccines Market Supply Chain Analysis
4. Global Veterinary Vaccines Market Trends and Strategies
5. Veterinary Vaccines Market Analysis of End Use Industries
7. Global Veterinary Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Veterinary Vaccines Total Addressable Market (TAM) Analysis for the Market
9. Veterinary Vaccines Market Segmentation
10. Veterinary Vaccines Market Regional and Country Analysis
11. Asia-Pacific Veterinary Vaccines Market
12. China Veterinary Vaccines Market
13. India Veterinary Vaccines Market
14. Japan Veterinary Vaccines Market
15. Australia Veterinary Vaccines Market
16. Indonesia Veterinary Vaccines Market
17. South Korea Veterinary Vaccines Market
18. Taiwan Veterinary Vaccines Market
19. South East Asia Veterinary Vaccines Market
20. Western Europe Veterinary Vaccines Market
21. UK Veterinary Vaccines Market
22. Germany Veterinary Vaccines Market
23. France Veterinary Vaccines Market
24. Italy Veterinary Vaccines Market
25. Spain Veterinary Vaccines Market
26. Eastern Europe Veterinary Vaccines Market
27. Russia Veterinary Vaccines Market
28. North America Veterinary Vaccines Market
29. USA Veterinary Vaccines Market
30. Canada Veterinary Vaccines Market
31. South America Veterinary Vaccines Market
32. Brazil Veterinary Vaccines Market
33. Middle East Veterinary Vaccines Market
34. Africa Veterinary Vaccines Market
36. Veterinary Vaccines Market Competitive Landscape and Company Profiles
37. Veterinary Vaccines Market Other Major and Innovative Companies
40. Veterinary Vaccines Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Veterinary Vaccines Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary vaccines market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Vaccine Type: Live Attenuated; Inactivated (Killed); Recombinant Or Subunit; mRNA And DNA; Other Vaccine Types2) By Animal Type: Canine; Feline; Equine; Bovine; Swine; Poultry; Other Animal Types
3) By Disease Type: Viral Diseases; Bacterial Diseases; Parasitic Diseases; Other Disease Types
4) By Route Of Administration: Injectable; Oral; Intranasal; Other Route Of Administrations
5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners; Farm Or Livestock Owners; Veterinary Clinics Or Hospitals; Animal Shelters Or Rescue Organizations; Research Or Educational Institutions
Subsegments:
1) By Live Attenuated: Viral Vaccines; Bacterial Vaccines; Parasitic Vaccines2) By Inactivated (Killed): Viral Vaccines; Bacterial Vaccines; Parasitic Vaccines
3) By Recombinant Or Subunit: Viral Vaccines; Bacterial Vaccines
4) By mRNA And DNA: Viral Vaccines; Bacterial Vaccines
5) By Other Vaccine Types: Toxoid Vaccines; Conjugate Vaccines; Vector-based Vaccines
Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Elanco Animal Health Incorporated; Ceva Santé Animale.; Virbac Group; HIPRA; Biogenesis Bago; Kyoritsu Seiyaku Corporation; Phibro Animal Health Corporation; Century Vaccines Limited; Bayer Animal Health; Cadila Vaccines Ltd.; Cargill India Pvt. Ltd.; China Animal Healthcare Ltd.; Jurox Pty Ltd; Nimrod Veterinary Products Ltd.; Bimeda; Animalcare; MSD Animal Health; Interfeed; Biotex Plus Ltd.; Belfarmacom; IDT Biologika; UCBVET; Lemavet; Syntec; Sauvet; Vetanco; Chemo Argentina; Brouwer; Agrovet Market Animal Health; DBK Pharma S.A.E.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Veterinary Vaccines market report include:- Zoetis Inc.
- Boehringer Ingelheim GmbH
- Merck & Co. Inc.
- Elanco Animal Health Incorporated
- Ceva Santé Animale.
- Virbac Group
- HIPRA
- Biogenesis Bago
- Kyoritsu Seiyaku Corporation
- Phibro Animal Health Corporation
- Century Vaccines Limited
- Bayer Animal Health
- Cadila Vaccines Ltd.
- Cargill India Pvt. Ltd.
- China Animal Healthcare Ltd.
- Jurox Pty Ltd
- Nimrod Veterinary Products Ltd.
- Bimeda
- Animalcare
- MSD Animal Health
- Interfeed
- Biotex Plus Ltd.
- Belfarmacom
- IDT Biologika
- UCBVET
- Lemavet
- Syntec
- Sauvet
- Vetanco
- Chemo Argentina
- Brouwer
- Agrovet Market Animal Health
- DBK Pharma S.A.E.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.28 Billion |
| Forecasted Market Value ( USD | $ 16.79 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
